AVOQ, LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION · â€‹Trade association.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 21, 2025

Bills named in this filing 1

Lobbying activity 4

Trade (domestic/foreign)

Issues related to international trade

Taxation/Internal Revenue Code

Issues related to the Vaccine Injury Compensation Program; General tax issues

Health Issues

General issues related to health care; H.R. 946, Optimizing Research Progress Hope And New Cures Act (ORPHAN) Cures Act

Science/Technology

Issues related to agricultural innovation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.